Search research articles
Contact Us
Filters
Showing results (991-1000 of 1,217) with videos related to
Page
of 122
Sort By:
Diabetes Care
|
January 20, 2023
Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study
Jelle M Beernink, Frederik Persson, Niels Jongs, et al.
Kidney International
|
November 26, 2016
Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
Vivekanand Jha, Mustafa Arici, Allan J Collins, et al.
European Stroke Journal
|
January 30, 2026
Associations of chronic kidney disease with recurrent stroke in patients with intracerebral haemorrhage
Philip S Nash, Simon Fandler-Höfler, Gareth Ambler, et al.
BMC Systems Biology
|
March 23, 2010
A novel approach to investigate tissue-specific trinucleotide repeat instability
Jong-Min Lee, Jie Zhang, Andrew I Su, et al.
Journal of the American Society of Nephrology : JASN
|
May 3, 2014
Effects of lowering LDL cholesterol on progression of kidney disease
Richard Haynes, David Lewis, Jonathan Emberson, et al.
Kidney International
|
April 17, 2019
Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Christopher T Chan, Peter J Blankestijn, Laura M Dember, et al.
Diabetes, Obesity & Metabolism
|
June 19, 2024
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial
Kathryn Cardoza, Amy Kang, Brendan Smyth, et al.
Kidney International Supplements
|
January 25, 2019
Reducing major risk factors for chronic kidney disease
Valerie A Luyckx, Katherine R Tuttle, Guillermo Garcia-Garcia, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 21, 2022
The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review
John P H Wilding, Marc Evans, Kevin Fernando, et al.
Clinical Kidney Journal
|
January 15, 2025
Iron management and exercise training in individuals with chronic kidney disease: lived experiences
Courtney J Lightfoot, Sharlene A Greenwood, Elham Asgari, et al.
Page
of 122
Search research articles
Search
Showing results (991-1000 of 1,217) with videos related to
Sort By:
Page
of 122
Diabetes Care
|
January 20, 2023
Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study
Jelle M Beernink, Frederik Persson, Niels Jongs, et al.
Kidney International
|
November 26, 2016
Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
Vivekanand Jha, Mustafa Arici, Allan J Collins, et al.
European Stroke Journal
|
January 30, 2026
Associations of chronic kidney disease with recurrent stroke in patients with intracerebral haemorrhage
Philip S Nash, Simon Fandler-Höfler, Gareth Ambler, et al.
BMC Systems Biology
|
March 23, 2010
A novel approach to investigate tissue-specific trinucleotide repeat instability
Jong-Min Lee, Jie Zhang, Andrew I Su, et al.
Journal of the American Society of Nephrology : JASN
|
May 3, 2014
Effects of lowering LDL cholesterol on progression of kidney disease
Richard Haynes, David Lewis, Jonathan Emberson, et al.
Kidney International
|
April 17, 2019
Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Christopher T Chan, Peter J Blankestijn, Laura M Dember, et al.
Diabetes, Obesity & Metabolism
|
June 19, 2024
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial
Kathryn Cardoza, Amy Kang, Brendan Smyth, et al.
Kidney International Supplements
|
January 25, 2019
Reducing major risk factors for chronic kidney disease
Valerie A Luyckx, Katherine R Tuttle, Guillermo Garcia-Garcia, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 21, 2022
The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review
John P H Wilding, Marc Evans, Kevin Fernando, et al.
Clinical Kidney Journal
|
January 15, 2025
Iron management and exercise training in individuals with chronic kidney disease: lived experiences
Courtney J Lightfoot, Sharlene A Greenwood, Elham Asgari, et al.
Page
of 122